Strain-Specific Differences in the Genetic Control of Two Closely Related Mycobacteria
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
The host response to mycobacterial infection depends on host and pathogen genetic factors. Recent studies in human populations suggest a strain specific genetic control of tuberculosis. To test for mycobacterial-strain specific genetic control of susceptibility to infection under highly controlled experimental conditions, we performed a comparative genetic analysis using the A/J- and C57BL/6J-derived recombinant congenic (RC) mouse panel infected with the Russia and Pasteur strains of Mycobacterium bovis Bacille Calmette Guérin (BCG). Bacillary counts in the lung and spleen at weeks 1 and 6 post infection were used as a measure of susceptibility. By performing genome-wide linkage analyses of loci that impact on tissue-specific bacillary burden, we were able to show the importance of correcting for strain background effects in the RC panel. When linkage analysis was adjusted on strain background, we detected a single locus on chromosome 11 that impacted on pulmonary counts of BCG Russia but not Pasteur. The same locus also controlled the splenic counts of BCG Russia but not Pasteur. By contrast, a locus on chromosome 1 which was indistinguishable from Nramp1 impacted on splenic bacillary counts of both BCG Russia and Pasteur. Additionally, dependent upon BCG strain, tissue and time post infection, we detected 9 distinct loci associated with bacillary counts. Hence, the ensemble of genetic loci impacting on BCG infection revealed a highly dynamic picture of genetic control that reflected both the course of infection and the infecting strain. This high degree of adaptation of host genetics to strain-specific pathogenesis is expected to provide a suitable framework for the selection of specific host-mycobacteria combinations during co-evolution of mycobacteria with humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“For all these models of infection, the Pklr mutation in AcB61 did not contribute to the clinical phenotype, and no further studies focusing on iron metabolism were performed.”
From Iron- and Hepcidin-Independent Downregulation of the Iron Exporter Ferroportin in Macrophages during Salmonella Infection (2017) · cites this paper as [27]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trunz, B. B., Fine, P., & Dye, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68507-3 · Cited by 1,114 · cited 1×
“On a population scale, BCG strains differ in the adverse reactions they trigger [31] and there is evidence that the protective effect of BCG vaccination against tuberculosis meningitis varies among ethnically divergent population groups [32].”
BackgroundNatural resistance to infection with intracellular parasites: isolation of a candidate for Bcg
Vidal, S. M., Malo, D., Vogan, K., Skamene, E., & Gros, P. (1993) · Cell · doi:10.1016/0092-8674(93)90135-d · Cited by 1,104
Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis
Mahairas, G. G., Sabo, P. J., Hickey, M. J., Singh, D. C., & Stover, C. K. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.5.1274-1282.1996 · Cited by 1,103 · cited 1×
“BCG Pasteur is characterized by the loss of RD2, nRD18, and RD14 [23,24,25] as well as a number of single point mutations and duplication events [22,23,26,27].”
BackgroundVariable host–pathogen compatibility in Mycobacterium tuberculosis
Gagneux, S., DeRiemer, K., Van, T., Kato-Maeda, M., de Jong, B. C., Narayanan, S., Nicol, M., Niemann, S., Kremer, K., Gutierrez, M. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511240103 · Cited by 971 · cited 1×
“tuberculosis strains with distinct ethnic populations [10,11].”
Pym, A. S., Brodin, P., Brosch, R., Huerre, M., & Cole, S. T. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03237.x · Cited by 729 · cited 1×
“difference 1 (RD1) [18,19].”
Gagneux, S., & Small, P. M. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70108-1 · Cited by 712 · cited 2×
“tuberculosis display substantial differences in their pathogenic potential [8,9].”
BackgroundDeletion of RD1 from Mycobacterium tuberculosis Mimics Bacille Calmette‐Guérin Attenuation
Lewis, K. N., Liao, R., Guinn, K. M., Hickey, M. J., Smith, S., Behr, M. A., & Sherman, D. R. (2003) · The Journal of Infectious Diseases · doi:10.1086/345862 · Cited by 588 · cited 1×
“difference 1 (RD1) [18,19].”
Self-citationGenome plasticity of BCG and impact on vaccine efficacy
Brosch, R., Gordon, S. V., Garnier, T., Eiglmeier, K., Frigui, W., Valenti, P., Dos Santos, S., Duthoy, S., Lacroix, C., Garcia-Pelayo, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700869104 · Cited by 574 · cited 2×
“BCG Pasteur is characterized by the loss of RD2, nRD18, and RD14 [23,24,25] as well as a number of single point mutations and duplication events [22,23,26,27].”
BackgroundSelf-citationThe Proteasome of Mycobacterium tuberculosis Is Required for Resistance to Nitric Oxide
Darwin, K. H., Ehrt, S., Gutierrez-Ramos, J.-C., Weich, N., & Nathan, C. F. (2003) · Science · doi:10.1126/science.1091176 · Cited by 535 · cited 1×
“inactivate microbicidal superoxide via katalase [1], avoid the detrimental effects of iNOS products [2], skew the antimycobacterial response in macrophages towards production of”
BackgroundThe lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans
Tobin, D. M., Vary, J. C., Ray, J. P., Walsh, G. S., Dunstan, S. J., Bang, N. D., Hagge, D. A., Khadge, S., King, M.-C., Hawn, T. R., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.013 · Cited by 528 · cited 1×
“anti-inflammatory molecules [3,4], and favour necrosis over apoptosis [5,6,7].”
BackgroundCaws, M., Thwaites, G., Dunstan, S., Hawn, T. R., Thi Ngoc Lan, N., Thuong, N. T. T., Stepniewska, K., Huyen, M. N. T., Bang, N. D., Huu Loc, T., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000034 · Cited by 498 · cited 1×
“detected preferential associations between a Toll-like receptor 2 (TLR2) polymorphism and tuberculosis meningitis caused by Beijing strains [12], as well as between variants of 59-lipoxygenase (ALOX5) and pulmonary tuberculosis caused by M.”
BackgroundMycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair
Divangahi, M., Chen, M., Gan, H., Desjardins, D., Hickman, T. T., Lee, D. M., Fortune, S., Behar, S. M., & Remold, H. G. (2009) · Nature Immunology · doi:10.1038/ni.1758 · Cited by 367 · cited 1×
“anti-inflammatory molecules [3,4], and favour necrosis over apoptosis [5,6,7].”
BackgroundChen, M., Divangahi, M., Gan, H., Shin, D. S. J., Hong, S., Lee, D. M., Serhan, C. N., Behar, S. M., & Remold, H. G. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080767 · Cited by 357 · cited 1×
“anti-inflammatory molecules [3,4], and favour necrosis over apoptosis [5,6,7].”
BackgroundGenetic control of natural resistance to Mycobacterium bovis (BCG) in mice.
Gros, P., Skamene, E., & Forget, A. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.6.2417 · Cited by 342 · cited 1×
“Overall, the pattern of tissue CFU for BCG Pasteur strongly resembled the one described for BCG Montreal which has previously been shown to be under Nramp1 control [35,38].”
ResultNg, V. H., Cox, J. S., Sousa, A. O., MacMicking, J. D., & McKinney, J. D. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04078.x · Cited by 342 · cited 1×
“inactivate microbicidal superoxide via katalase [1], avoid the detrimental effects of iNOS products [2], skew the antimycobacterial response in macrophages towards production of”
BackgroundBlack, G. F., Weir, R. E., Floyd, S., Bliss, L., Warndorff, D. K., Crampin, A. C., Ngwira, B., Sichali, L., Nazareth, B., Blackwell, J. M., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08353-8 · Cited by 306 · cited 1×
“For example, the immunogenicity of the same strain of BCG given to vaccinees of different genetic background can vary tremendously [28,29] while host responses triggered by different strains of BCG are equally divergent [30].”
BackgroundA historical and molecular phylogeny of BCG strains
Behr, M. A., & Small, P. M. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00277-1 · Cited by 242 · cited 3×
“among the most phylogenetically distant BCG strains [15].”
BackgroundSelf-citationIntemann, C. D., Thye, T., Niemann, S., Browne, E. N. L., Amanua Chinbuah, M., Enimil, A., Gyapong, J., Osei, I., Owusu-Dabo, E., Helm, S., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000577 · Cited by 227 · cited 2×
“tuberculosis [14].”
D�mant, P., & Hart, A. A. M. (1986) · Immunogenetics · doi:10.1007/bf00377961 · Cited by 201 · cited 2×
“RC strains are particularly useful to establish pathways of causality in complex read-outs such as immune reactivity and are well suited to track gene-gene interactions [33].”
BackgroundGreenwood, C. M. T., Fujiwara, T. M., Boothroyd, L. J., Miller, M. A., Frappier, D., Fanning, E. A., Schurr, E., & Morgan, K. (2000) · The American Journal of Human Genetics · doi:10.1086/303012 · Cited by 200 · cited 1×
“Interestingly, the strongest genetic effect ever found in human studies was found in an outbreak of tuberculosis in Northern Canada [44].”
BackgroundSelf-citationGan, H., Lee, J., Ren, F., Chen, M., Kornfeld, H., & Remold, H. G. (2008) · Nature Immunology · doi:10.1038/ni.1654 · Cited by 192
Oettinger, T., Jørgensen, M., Ladefoged, A., Hasløv, K., & Andersen, P. (1999) · Tubercle and Lung Disease · doi:10.1054/tuld.1999.0206 · Cited by 190 · cited 1×
“bovis through in vitro propagation [15,16,17].”
Major Mycobacterium tuberculosis Lineages Associate with Patient Country of Origin
Reed, M. B., Pichler, V. K., McIntosh, F., Mattia, A., Fallow, A., Masala, S., Domenech, P., Zwerling, A., Thibert, L., Menzies, D., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02142-08 · Cited by 181 · cited 1×
“tuberculosis strains with distinct ethnic populations [10,11].”
Self-citationBCG Vaccines: Their mechanisms of attenuation and impact on safety and protective efficacy
Liu, J., Tran, V., Leung, A. S., Alexander, D. C., & Zhu, B. (2009) · Human Vaccines · doi:10.4161/hv.5.2.7210 · Cited by 146 · cited 3×
“Recombinant BCG Russia (ATCC 35740) and Pasteur (ATCC 35734), were transformed with pGH1, an integrating vector that inserts into the attB site of the mycobacterial genome and that combines a firefly luciferase lux gene cassette, an integrase [int] gene, a MOP promoter, and a hygromycin resistance [Hyg] gene [31].”
BackgroundMethodThe clinical consequences of strain diversity in Mycobacterium tuberculosis
Nicol, M. P., & Wilkinson, R. J. (2008) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2008.03.025 · Cited by 145 · cited 2×
“tuberculosis display substantial differences in their pathogenic potential [8,9].”
BackgroundThe in vitro evolution of BCG vaccines
Mostowy, S., Tsolaki, A. G., Small, P. M., & Behr, M. A. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00484-5 · Cited by 140 · cited 1×
“Genetic events identified in BCG Russia include the deletion of RD Russia (Rv3698) [20], an insertion mutation in the recA gene (recA_D140*) [21], and the presence of an IS6110 element in the promoter region of the phoP gene [15,22].”
BackgroundPyruvate kinase deficiency in mice protects against malaria
Min-Oo, G., Fortin, A., Tam, M.-F., Nantel, A., Stevenson, M. M., & Gros, P. (2003) · Nature Genetics · doi:10.1038/ng1260 · Cited by 133 · cited 1×
“However, RC strains have also proven useful for positional identification of disease susceptibility loci by employing RC strains with extreme phenotypes in subsequent genetic crosses [39,40,41].”
BackgroundFortin, A., Diez, E., Rochefort, D., Laroche, L., Malo, D., Rouleau, G. A., Gros, P., & Skamene, E. (2001) · Genomics · doi:10.1006/geno.2001.6528 · Cited by 116 · cited 1×
“. The AcB/BcA panel used in the present study was derived from a reciprocal double backcross between C57BL/6J and A/J”
MethodCharlet, D., Mostowy, S., Alexander, D. C., Sit, L., Wiker, H. G., & Behr, M. A. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04618.x · Cited by 113 · cited 1×
“BCG Pasteur is characterized by the loss of RD2, nRD18, and RD14 [23,24,25] as well as a number of single point mutations and duplication events [22,23,26,27].”
BackgroundSelf-citationPopulation Differences in Immune Responses to Bacille Calmette‐Guérin Vaccination in Infancy
Lalor, M. K., Ben‐Smith, A., Gorak‐Stolinska, P., Weir, R. E., Floyd, S., Blitz, R., Mvula, H., Newport, M. J., Branson, K. R., McGrath, N. M., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/597069 · Cited by 108 · cited 1×
“For example, the immunogenicity of the same strain of BCG given to vaccinees of different genetic background can vary tremendously [28,29] while host responses triggered by different strains of BCG are equally divergent [30].”
BackgroundBehr, M. A., Schroeder, B. G., Brinkman, J. N., Slayden, R. A., & Barry, C. E. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.12.3394-3399.2000 · Cited by 106 · cited 1×
“BCG Pasteur is characterized by the loss of RD2, nRD18, and RD14 [23,24,25] as well as a number of single point mutations and duplication events [22,23,26,27].”
BackgroundSelf-citationALOX5 variants associated with susceptibility to human pulmonary tuberculosis
Herb, F., Thye, T., Niemann, S., Browne, E. N. L., Chinbuah, M. A., Gyapong, J. O., Osei, I., Owusu‐Dabo, E., Werz, O., Rüsch–Gerdes, S., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm378 · Cited by 99 · cited 2×
“tuberculosis [13].”
Detection of Deleted Genomic DNA Using a Semiautomated Computational Analysis of GeneChip Data
Salamon, H., Kato-Maeda, M., Small, P. M., Drenkow, J., & Gingeras, T. R. (2000) · Genome Research · doi:10.1101/gr.152900 · Cited by 72 · cited 1×
“BCG Pasteur is characterized by the loss of RD2, nRD18, and RD14 [23,24,25] as well as a number of single point mutations and duplication events [22,23,26,27].”
Background(2008) · Wiley eBooks · doi:10.1002/9783527611614 · Cited by 64
Wu, B., Huang, C., García‐García, L., Ponce‐de‐León, A., Sifuentes‐Osornio, J., Bobadilla-del-Valle, M., Ferreira, L., Canizales‐Quintero, S., Small, P. M., Kato‐Maeda, M., et al. (2007) · Infection and Immunity · doi:10.1128/iai.00244-07 · Cited by 61 · cited 1×
“For example, the immunogenicity of the same strain of BCG given to vaccinees of different genetic background can vary tremendously [28,29] while host responses triggered by different strains of BCG are equally divergent [30].”
BackgroundSpreadbury, C. L., Pallen, M. J., Overton, T. W., Behr, M. A., Mostowy, S., Spiro, S., Busby, S. J. W., & Cole, J. A. (2005) · Microbiology · doi:10.1099/mic.0.27444-0 · Cited by 54 · cited 1×
“BCG Pasteur is characterized by the loss of RD2, nRD18, and RD14 [23,24,25] as well as a number of single point mutations and duplication events [22,23,26,27].”
BackgroundSelf-citationIs susceptibility to tuberculosis acquired or inherited?
Schurr, E. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01741.x · Cited by 54 · cited 1×
“a single bacterial strain [45].”
Self-citationTuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutant
Keller, P. M., Böttger, E. C., & Sander, P. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-120 · Cited by 42
Impact of Methoxymycolic Acid Production by Mycobacterium bovis BCG Vaccines
Belley, A., Alexander, D. C., Pietrantonio, T. D., Girard, M., Jones, J., Schurr, E., Liu, J., Sherman, D. R., & Behr, M. A. (2004) · Infection and Immunity · doi:10.1128/iai.72.5.2803-2809.2004 · Cited by 38 · cited 1×
“The pGH1 vector allows for growth on antibiotic-containing media to reduce risk of contamination [36].”
BackgroundSelf-citationPyruvate kinase deficiency confers susceptibility to Salmonella typhimurium infection in mice
Roy, M.-F., Riendeau, N., Bédard, C., Hélie, P., Min-Oo, G., Turcotte, K., Gros, P., Canonne-Hergaux, F., & Malo, D. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062606 · Cited by 35 · cited 1×
“However, RC strains have also proven useful for positional identification of disease susceptibility loci by employing RC strains with extreme phenotypes in subsequent genetic crosses [39,40,41].”
BackgroundTB: Screening for Responses to a Vile Visitor
Behr, M. A., Schurr, E., & Gros, P. (2010) · Cell · doi:10.1016/j.cell.2010.02.030 · Cited by 30 · cited 1×
“anti-inflammatory molecules [3,4], and favour necrosis over apoptosis [5,6,7].”
BackgroundSelf-citationCamateros, P., Marino, R., Fortin, A., Martin, J. G., Skamene, E., SLADEK, R. M., & Radzioch, D. (2009) · Mammalian Genome · doi:10.1007/s00335-009-9236-z · Cited by 18 · cited 1×
“For example, a recent study used the AcB/BcA RC strain panel to localize a large number of asthma susceptibility loci across the genome [42].”
ResultGenetic Control of Host Susceptibility to Tuberculosis
Schurr, E., & Kramnik, I. (2008) · Wiley eBooks · doi:10.1002/9783527611614.ch29 · Cited by 17
Self-citationUse of Recombinant Congenic Strains in Mapping Disease-Modifying Genes
Müllerová, J., & Hozák, P. (2004) · Physiology · doi:10.1152/nips.01512.2003 · Cited by 8 · cited 1×
“However, RC strains have also proven useful for positional identification of disease susceptibility loci by employing RC strains with extreme phenotypes in subsequent genetic crosses [39,40,41].”
BackgroundGros, P., Skamene, E., Forget, A., & Taylor, B. (1983) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-4481-0_17 · Cited by 4
Research works printed but not linked: 1
- Calmette A Guérin C Breton M 1907 Contribution à l'étude de la tuberculose expérimentale du cobaye. Ann Inst Pasteur 401 416
Cited by
Human genetics of tuberculosis: a long and winding road
Abel, L., El-Baghdadi, J., Bousfiha, A. A., Casanova, J.-L., & Schurr, E. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0428 · Cited by 187
Self-citationAbel, L., Fellay, J., Haas, D. W., Schurr, E., Srikrishna, G., Urbanowski, M., Chaturvedi, N., Srinivasan, S., Johnson, D. H., & Bishai, W. R. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30623-0 · Cited by 171
Self-citationMycobacterial Dormancy Systems and Host Responses in Tuberculosis
Peddireddy, V., Doddam, S. N., & Ahmed, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00084 · Cited by 172
“Interestingly, the ability of the host genetic control depends on the mycobacterial strain encountered and the exposure intensity (151).”
BackgroundMcHenry, M. L., Bartlett, J., Igo, R. P., Wampande, E. M., Benchek, P. H., Mayanja‐Kizza, H., Fluegge, K., Hall, N. B., Gagneux, S., Tishkoff, S. A., et al. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008728 · Cited by 83
Огарков, О. Б., Владиславович, М. И., Sinkov, V. V., Николаевна, Ж. С., Antipina, S., & Савилов, Е. Д. (2011) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2011.10.005 · Cited by 57
Metadata
- Authors
- Di Pietrantonio, T., Hernandez, C., Girard, M., Verville, A., Orlova, M., Belley, A., Behr, M. A., Loredo-Osti, J. C., & Schurr, E.
- Affiliations
- Research Institute of the McGill University Health Centre (CA)
- Corresponding author
- Schurr, Erwin
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-10-28
- Volume
- 6
- Issue
- 10
- Pages
- e1001169
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC2965770
- OpenAlex
- W2088904392
- Cited by
- 21
- References
- 45
- Citations by year
- 2024: 1 · 2020: 3 · 2019: 1 · 2017: 5 · 2014: 3 · 2013: 4 · 2012: 1
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Memorial University Research Repository (Memorial University) (acceptedVersion)
- eScholarship@McGill (McGill) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship@McGill (McGill) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Memorial University Research Repository (Memorial University) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- Canadian Institutes of Health Research
- National Heart, Lung, and Blood Institute (R01HL068533, HL68533)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- Mycobacterium bovis BCG, tuberculosis susceptibility, NRAMP1, host-pathogen coevolution, host genetic susceptibility
- MeSH terms
- Animals, Chromosome Mapping, Genetic Linkage, Lung, Mice, Inbred C57BL, Mycobacterium, Mycobacterium bovis, Mycobacterium Infections, Species Specificity, Spleen, Colony Count, Microbial, Gene Expression Regulation, Bacterial, Animals, Inbred Strains, Genetic Speciation, Mice, Host-Pathogen Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.